This site aims to provide an extensive and free-access toolbox to facilitate the professional coverage of Solvay news.
Members of the press can also contact Solvay spokespersons worldwide for further information and assistance.
Latest news
December 16, 2008Solvay welcomes FDA approval for Trilipix™ (fenofibric acid) New therapy in combination with a statin helped patients improve HDL and LDL cholesterol and triglycerides in clinical studies [EN]-[FR]-[NL]
December 03, 2008Solvay takes stake in fuel cell developer ACAL Energy Investment in innovative low-cost and high reliability fuel cell technology [EN]-[FR]-[NL]
December 02, 2008Solvay succesfully completes pre-registration of 400 substances in accordance with the REACH regulation (EC) no 1907/2006 Pre-registration is first main step in Solvay’s commitment to fulfill REACH obligations for its products [EN]-[FR]-[NL]
